Apply for a COVID-19 Pivot Grant

Request for Applications:  2020 COVID-19 PIVOT GRANT (3rd Round)

RFA Released: September 8, 2020
Applications Due: October 30, 2020
5:00 PM EST
Notification of Awards: December 2020

The Autism Science Foundation invites applications for a third round of the COVID-19 Pivot Grant Program. This funding is intended to help researchers manage changes in research projects due to the COVID-19 emergency. 

The funding will not fully support a project, but rather is meant to help support new costs encountered due to adaptations or modifications to an original research plan as a result of the current shutdown across research institutions.

The current RFA is limited to scientists early in their career with an established university or research institution affiliation. Early career investigators are defined by ASF as those from pre-doctoral training to up to 7 years after completion of a postdoctoral fellowship or following medical training including the internship and fellowship. Pre and post-doctoral fellows are required to ensure that a letter of support is sent to ASF from their mentor or PI on the existing grant.

Awards:

The Autism Science Foundation will make a number of Awards determined by its available financial resources. The term of the award cannot exceed the IRB approval period or the changes approved by the IRB for the alterations to the research plan.

Grants of up to $3000 are available for a 6-month term to help researchers conform to current restrictions due to the COVID-19 emergency. All changes in protocol to the initial project must have prior IRB approval, if applicable. Changes to animal care protocols must be approved by the appropriate review boards at your research institution. If you have applied for IRB approval but have not received it yet, you are not eligible at this time. No portion of these funds shall be used to cover indirect university costs. 

Be creative in your use of these funds! Some examples of how funds can be used are:

  1. Honorariums associated with participant retention in research;
  2. Costs of new biological agents or preparations proposed to either pivot or readjust the research plan;
  3. Direct storage costs of biological agents to preserve previously acquired samples; 
  4. Costs of technological platforms or technological tools to collect data from families remotely; 
  5. Costs associated with making various materials available to families or to other researchers which were not intended in the original proposal.  These can include infrastructure to support sharing or dissemination expenses.

Questions about proposal submission, proposal content and review, or applicant eligibility should be addressed to Casey Gold-Casey, Director of Operations, Autism Science Foundation. (cgold@autismsciencefoundation.org)